Pharmacological interventions for the correction of ion transport defect in cystic fibrosis

This publication has 63 references indexed in Scilit:

• Rescue of functional ΔF508‐CFTR channels by co‐expression with truncated CFTR constructs in COS‐1 cells
  FEBS Letters, 2003
• Benzoquinolines and chloride secretion in murine colonic epithelium
  British Journal of Pharmacology, 2003
• Benzo(c)quinolizinium drugs inhibit degradation of ΔF508-CFTR cytoplasmic domain
  Biochemical and Biophysical Research Communications, 2003
• Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targeting
  Advanced Drug Delivery Reviews, 2002
• The Cystic Fibrosis Mutation G551D Alters the Non-Michaelis-Menten Behavior of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel and Abolishes the Inhibitory Genistein Binding Site
  Published by Elsevier ,2002
• A Short Segment of the R Domain of Cystic Fibrosis Transmembrane Conductance Regulator Contains Channel Stimulatory and Inhibitory Activities That Are Separable by Sequence Modification
  Published by Elsevier ,2002
• Phenanthrolines – a new class of CFTR chloride channel openers
  British Journal of Pharmacology, 2001
• Direct Activation of Cystic Fibrosis Transmembrane Conductance Regulator Channels by 8-Cyclopentyl-1,3-dipropylxanthine (CPX) and 1,3-Diallyl-8-cyclohexylxanthine (DAX)
  Published by Elsevier ,1998
• Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel
  British Journal of Pharmacology, 1998
• A1 Receptor Antagonist 8-Cyclopentyl-1,3-dipropylxanthine Selectively Activates Chloride Efflux from Human Epithelial and Mouse Fibroblast Cell Lines Expressing the Cystic Fibrosis Transmembrane Regulator .DELTA.F508 Mutation
  Biochemistry, 1995